Wolverine Trading’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $52.7M | Buy |
206,300
+11,200
| +6% | +$2.95M | 0.04% | 304 |
|
|
2025
Q2 | $47.2M | Buy |
195,100
+7,800
| +4% | +$1.94M | 0.05% | 264 |
|
|
2025
Q1 | $49.6M | Sell |
187,300
-57,200
| -23% | -$15.5M | 0.06% | 210 |
|
|
2024
Q4 | $62.2M | Sell |
244,500
-22,700
| -8% | -$6.09M | 0.06% | 194 |
|
|
2024
Q3 | $85.4M | Buy |
267,200
+132,400
| +98% | +$47.1M | 0.09% | 125 |
|
|
2024
Q2 | $50.4M | Sell |
134,800
-14,300
| -10% | -$4.83M | 0.05% | 193 |
|
|
2024
Q1 | $51.7M | Buy |
149,100
+29,700
| +25% | +$11.3M | 0.05% | 185 |
|
|
2023
Q4 | $54.7M | Buy |
119,400
+53,000
| +80% | +$26.1M | 0.06% | 188 |
|
|
2023
Q3 | $32.3M | Sell |
66,400
-9,800
| -13% | -$4.61M | 0.03% | 244 |
|
|
2023
Q2 | $33.8M | Buy |
76,200
+27,800
| +57% | +$14M | 0.04% | 235 |
|
|
2023
Q1 | $23.6M | Buy |
+48,400
| New | +$23.9M | 0.04% | 308 |
|
|
2022
Q4 | – | Sell |
-59,400
| Closed | -$29.2M | – | 4429 |
|
|
2022
Q3 | $29.2M | Buy |
59,400
+28,600
| +93% | +$13.9M | 0.05% | 224 |
|
|
2022
Q2 | $14.4M | Buy |
30,800
+2,900
| +10% | +$1.29M | 0.02% | 403 |
|
|
2022
Q1 | $12.3M | Sell |
27,900
-49,300
| -64% | -$20.6M | 0.02% | 606 |
|
|
2021
Q4 | $36M | Sell |
77,200
-4,400
| -5% | -$1.95M | 0.04% | 310 |
|
|
2021
Q3 | $32.3M | Buy |
81,600
+20,200
| +33% | +$8.57M | 0.04% | 356 |
|
|
2021
Q2 | $27.2M | Buy |
61,400
+8,300
| +16% | +$3.63M | 0.04% | 317 |
|
|
2021
Q1 | $22.6M | Sell |
53,100
-5,400
| -9% | -$2.16M | 0.03% | 359 |
|
|
2020
Q4 | $23.8M | Buy |
58,500
+17,200
| +42% | +$7.15M | 0.04% | 355 |
|
|
2020
Q3 | $16.6M | Sell |
41,300
-2,700
| -6% | -$1.09M | 0.04% | 355 |
|
|
2020
Q2 | $16.7M | Sell |
44,000
-11,700
| -21% | -$4.38M | 0.05% | 298 |
|
|
2020
Q1 | $17.3M | Sell |
55,700
-34,700
| -38% | -$11.7M | 0.05% | 261 |
|
|
2019
Q4 | $33.2M | Sell |
90,400
-14,200
| -14% | -$4.5M | 0.08% | 186 |
|
|
2019
Q3 | $26.9M | Buy |
+104,600
| New | +$29.3M | 0.08% | 196 |
|
|
2019
Q2 | – | Sell |
-81,500
| Closed | -$21.7M | – | 4737 |
|
|
2019
Q1 | $21.7M | Sell |
81,500
-4,000
| -5% | -$1.15M | 0.06% | 237 |
|
|
2018
Q4 | $24.1M | Buy |
85,500
+11,000
| +15% | +$3.49M | 0.07% | 201 |
|
|
2018
Q3 | $25.2M | Buy |
74,500
+39,800
| +115% | +$12.9M | 0.06% | 238 |
|
|
2018
Q2 | $9.33M | Hold |
34,700
| – | – | 0.02% | 538 |
|
|
2018
Q1 | $9.33M | Buy |
34,700
+8,200
| +31% | +$2.22M | 0.02% | 538 |
|
|
2017
Q4 | $6.57M | Buy |
26,500
+7,200
| +37% | +$1.78M | 0.02% | 703 |
|
|
2017
Q3 | $4.7M | Sell |
19,300
-1,500
| -7% | -$368K | 0.02% | 800 |
|
|
2017
Q2 | $4.98M | Sell |
20,800
-21,000
| -50% | -$4.75M | 0.02% | 670 |
|
|
2017
Q1 | $8.65M | Sell |
41,800
-158,000
| -79% | -$32.7M | 0.05% | 403 |
|
|
2016
Q4 | $40.8M | Buy |
199,800
+7,000
| +4% | +$1.34M | 0.2% | 86 |
|
|
2016
Q3 | $33.9M | Buy |
192,800
+75,400
| +64% | +$13.1M | 0.16% | 122 |
|
|
2016
Q2 | $21.6M | Buy |
+117,400
| New | +$20.9M | 0.12% | 155 |
|
Other funds holding HUM
Wolverine Trading's HUM Position: Q3 2025 in Review
Wolverine Trading increased its Humana (HUM) stake by 35% in Q3 2025, buying an estimated $3.78M and bringing the position to 55,633 shares worth $14.2M. The position accounts for 0.01% of the portfolio, ranked #756.
Wolverine Trading first reported a position in HUM in Q2 2016 and has held it in 34 quarters since. The position peaked at $15.5M in Q4 2023. 892 funds tracked by Wall St. Rank hold HUM as of Q3 2025.
- Wolverine Trading held 55,633 shares of Humana worth $14.2M as of Q3 2025.
- Wolverine Trading bought 14,372 Humana shares in Q3 2025, an estimated $3.78M.
- Humana made up 0.01% of Wolverine Trading's portfolio in Q3 2025, its #756 holding.
- Wolverine Trading first reported a position in Humana in Q2 2016 and has held it in 34 quarters since.
- Wolverine Trading's Humana position peaked at $15.5M in Q4 2023.
- 892 funds tracked by Wall St. Rank held Humana as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.